Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
PPD Inc (PPD), a subsidiary of Thermo Fisher Scientific Inc, is a pharmaceutical company that carries out drug development, laboratory and lifecycle management services. It offers clinical development and laboratories solution. The company's clinical services include early development, clinical trial management, biostatics, peri- and post-approval, site and patient-centric solutions, product development and consulting, technology and innovation, decentralized clinical trials and information security among others. PPD's laboratory services include bioanalytical lab, bioanalytical lab experience and expertise, biomarker lab, biomarker lab resource, central lab, central lab capabilities, GMP lab experience and expertise and vaccine science lab, among others. It serves government organizations, medical device, pharmaceutical and biotechnology companies. The company operates in the US, the UK, Canada, Japan, Sweden and Germany among others. PPD is headquartered in Wilmington, North Carolina, the US.
PPD Inc premium industry data and analytics
Products and Services
| Services | Brands |
|---|---|
| Clinical Developments: | PPD |
| Early Development | |
| EDS Global Capabilities | |
| XYZ | |
| XYZ | |
| XYZ |
Competitor Comparison
| Key Parameters | PPD Inc | IQVIA Holdings Inc | United Therapeutics Corp | Medpace Holdings Inc | Parexel International Corp |
|---|---|---|---|---|---|
| Headquarters | United States of America | United States of America | United States of America | United States of America | United States of America |
| City | Wilmington | Durham | Silver Spring | Cincinnati | Raleigh |
| State/Province | North Carolina | North Carolina | Maryland | Ohio | North Carolina |
| No. of Employees | 30,000 | 93,000 | 1,400 | 5,900 | 24,000 |
| Entity Type | Private | Public | Public | Public | Private |
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| David Simmons | Chief Executive Officer; Chairman | Executive Board | - | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer